BackDare Bioscience Overview

Dare Bioscience Receivables

Track Dare Bioscience's receivables ($690K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$687756.00
553.55% YoYΔ $582522.00 vs prior year quarter

Peer trimmed avg / median

Loading

Dare Bioscience Receivables History

Loading

Dare Bioscience vs. peers: Receivables Comparison

Loading

Dare Bioscience Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Dare Bioscience (DARE) FAQ

As of the most recent data (March 2026), DARE shows a receivables of $690K. That compares with $110K in the prior-year period — up 553.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DARE's receivables is now $690K (was $110K) — a 553.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Dare Bioscience is outperforming or lagging.

Tracking DARE's receivables over time shows whether Dare Bioscience is scaling, shrinking, or reshaping that part of the business. The current reading is $690K That compares with $110K in the prior-year period — up 553.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Dare Bioscience's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $690K) with ownership activity and broader fundamentals.

Dare Bioscience's receivables is $690K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.